Upgrade to SI Premium - Free Trial

Needham & Company Raises Price Target on Sapiens (SPNS) Following a Solid 4Q and Upbeat Guidance

February 17, 2016 2:00 PM

Needham & Company reiterated a Buy rating on Sapiens International Corp. NV (NASDAQ: SPNS), and raised the price target to $15.00 (from $14.00), following the company's 4Q earnings report. SPNS reported 4Q revenue of $48.7 million, up 16.5% Y/Y, in-line with Needham's $48.8 million estimate. SPNS posted $0.13 in EPS, a penny above consensus. Management introduced upbeat FY16 guidance that is above consensus, with revenue guidance of $207-211 million.

Analyst Mayank Tandon commented, "Sapiens (SPNS) delivered another solid quarter, comfortably exceeding our and consensus estimates, to finish FY15 on a strong note. Customer demand and win rates remain healthy as SPNS continues to benefit from the secular tailwinds as insurance carriers move from in-house to third-party software solutions. Management introduced upbeat guidance for FY16 that is not only above consensus but also calls for another year of 15%+ organic growth and operating margin expansion. We are raising our FY16 estimates, introducing a strong growth outlook for FY17, and raising our target to $15. We continue to see SPNS as a solid fit for small-cap GARP portfolios and we reiterate our BUY rating."

For an analyst ratings summary and ratings history on Sapiens International Corp. NV click here. For more ratings news on Sapiens International Corp. NV click here.

Shares of Sapiens International Corp. NV closed at $10.08 yesterday.

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles